Last reviewed · How we verify
Droperidol injection
Droperidol injection is a dopamine antagonist that blocks dopamine receptors in the brain.
Droperidol injection is a dopamine antagonist that blocks dopamine receptors in the brain. Used for Prevention of nausea and vomiting caused by chemotherapy.
At a glance
| Generic name | Droperidol injection |
|---|---|
| Also known as | D |
| Sponsor | CHRISTUS Health |
| Drug class | typical antipsychotic |
| Target | D1 receptor |
| Modality | Small molecule |
| Therapeutic area | Psychiatry |
| Phase | Phase 2 |
Mechanism of action
Droperidol works by blocking dopamine receptors, which can help to reduce symptoms of psychosis and anxiety. It is a typical antipsychotic medication that can also have sedative effects.
Approved indications
- Prevention of nausea and vomiting caused by chemotherapy
Common side effects
- Drowsiness
- Dizziness
- Headache
Key clinical trials
- Supra Inguinal Fascia Iliaca Block as Rescue Analgesia Following Total Hip Arthroplasty (NA)
- Droperidol and QTc Interval Changes in ED Patients
- Optimization of Procedural Sedation Protocol Used for Dental Care Delivery in People With Mental Disability (PHASE4)
- Low-dose Droperidol for Prevention of Postoperative Delirium in Elderly Patients After Non-cardiac Surgery (NA)
- Droperidol on Prevention of Cannabis Hyperemesis Syndrome (PHASE3)
- Gender Influence on Torsadogenic Actions of Droperidol. (NA)
- Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair (NA)
- A Fast-track Versus Conventional Recovery Protocol in Laparoscopic Hysterctomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |